Lorcaserin Extended-Release Tablets and Tafenoquine Succinate (Arakoda)
Determining the interaction of Lorcaserin Extended-Release Tablets and Tafenoquine Succinate (Arakoda) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Tafenoquine Succinate (Krintafel)
- Lorcaserin Extended-Release Tablets-Tafinlar
- Lorcaserin Extended-Release Tablets-Tafluprost
- Lorcaserin Extended-Release Tablets-Tafluprost ophthalmic
- Lorcaserin Extended-Release Tablets-Tagamet
- Lorcaserin Extended-Release Tablets-Tagamet HB
- Tafenoquine Succinate (Arakoda)-Lorcaserin Hydrochloride
- Tafenoquine Succinate (Arakoda)-Lorcaserin Tablets
- Tafenoquine Succinate (Arakoda)-Lorcet
- Tafenoquine Succinate (Arakoda)-Lorcet Plus
- Tafenoquine Succinate (Arakoda)-Lorcet Tablets
- Tafenoquine Succinate (Arakoda)-Lorlatinib